View ValuationArborGen Holdings 향후 성장Future 기준 점검 4/6ArborGen Holdings (는) 각각 연간 104% 및 5.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 104.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 2% 로 예상됩니다.핵심 정보104.0%이익 성장률104.37%EPS 성장률Forestry 이익 성장26.1%매출 성장률5.4%향후 자기자본이익률2.00%애널리스트 커버리지Low마지막 업데이트12 Aug 2026최근 향후 성장 업데이트공고 • Nov 29ArborGen Holdings Limited Revises Group Earnings Guidance for the Full Year 2025ArborGen Holdings Limited revised group earnings guidance for the full year 2025. The company's overall goal remains to drive sales of its advanced genetics seedlings in its target markets in the US South and Brazil, both of which offer strong growth and commercial potential. Growth momentum and higher volumes are expected in Brazil in second half of 2025 following the softer first half year. Headwinds in the US South are expected to continue to impact across the industry, resulting in lower demand and offsetting the growth in Brazil. Given this, the company expects full year 2025 sales volumes to be down on last year with a corresponding impact on earnings.모든 업데이트 보기Recent updatesNew Risk • Jul 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of New Zealander stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$400k free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$226k net loss in 2 years). Share price has been volatile over the past 3 months (6.2% average weekly change). Market cap is less than US$100m (NZ$33.0m market cap, or US$19.3m).공고 • Jul 13ArborGen Holdings Limited, Annual General Meeting, Sep 15, 2026ArborGen Holdings Limited, Annual General Meeting, Sep 15, 2026.New Risk • Jun 02New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$7.5m Forecast net loss in 2 years: US$226k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$400k free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$226k net loss in 2 years). Market cap is less than US$100m (NZ$44.6m market cap, or US$26.5m).Reported Earnings • May 30Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: US$0.015 loss per share (improved from US$0.041 loss in FY 2025). Revenue: US$68.2m (up 7.9% from FY 2025). Net loss: US$7.50m (loss narrowed 65% from FY 2025). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 8.2% p.a. on average during the next 2 years, compared to a 5.0% growth forecast for the Global Forestry industry. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.New Risk • Apr 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of New Zealander stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$5.1m free cash flow). Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Market cap is less than US$100m (NZ$45.1m market cap, or US$26.4m).Reported Earnings • Nov 28First half 2026 earnings released: US$0.001 loss per share (vs US$0.004 loss in 1H 2025)First half 2026 results: US$0.001 loss per share (improved from US$0.004 loss in 1H 2025). Revenue: US$14.2m (up 11% from 1H 2025). Net loss: US$600.0k (loss narrowed 71% from 1H 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.New Risk • Sep 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of New Zealander stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$5.1m free cash flow). Earnings have declined by 67% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Market cap is less than US$100m (NZ$64.0m market cap, or US$37.8m).Recent Insider Transactions • Aug 30President & CEO recently bought NZ$82k worth of stockOn the 28th of August, Justin Birch bought around 750k shares on-market at roughly NZ$0.11 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Justin's only on-market trade for the last 12 months.분석 기사 • Jul 24Cautious Investors Not Rewarding ArborGen Holdings Limited's (NZSE:ARB) Performance CompletelyThere wouldn't be many who think ArborGen Holdings Limited's ( NZSE:ARB ) price-to-sales (or "P/S") ratio of 0.5x is...공고 • Jul 11ArborGen Holdings Limited, Annual General Meeting, Sep 10, 2025ArborGen Holdings Limited, Annual General Meeting, Sep 10, 2025. Location: auckland New ZealandReported Earnings • May 31Full year 2025 earnings released: US$0.041 loss per share (vs US$0 in FY 2024)Full year 2025 results: US$0.041 loss per share (further deteriorated from US$0 in FY 2024). Revenue: US$63.2m (down 6.6% from FY 2024). Net loss: US$21.5m (loss widened US$21.3m from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 107 percentage points per year, which is a significant difference in performance.New Risk • May 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$5.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$5.1m free cash flow). Earnings have declined by 67% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NZ$76.6m market cap, or US$45.8m).공고 • Nov 29ArborGen Holdings Limited Revises Group Earnings Guidance for the Full Year 2025ArborGen Holdings Limited revised group earnings guidance for the full year 2025. The company's overall goal remains to drive sales of its advanced genetics seedlings in its target markets in the US South and Brazil, both of which offer strong growth and commercial potential. Growth momentum and higher volumes are expected in Brazil in second half of 2025 following the softer first half year. Headwinds in the US South are expected to continue to impact across the industry, resulting in lower demand and offsetting the growth in Brazil. Given this, the company expects full year 2025 sales volumes to be down on last year with a corresponding impact on earnings.Reported Earnings • Nov 29First half 2025 earnings released: US$0.004 loss per share (vs US$0 in 1H 2024)First half 2025 results: US$0.004 loss per share (further deteriorated from US$0 in 1H 2024). Revenue: US$12.8m (down 3.0% from 1H 2024). Net loss: US$2.10m (loss widened US$2.00m from 1H 2024). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.공고 • Jul 22ArborGen Holdings Limited, Annual General Meeting, Aug 26, 2024ArborGen Holdings Limited, Annual General Meeting, Aug 26, 2024. Location: hunterville room, ellerslie event centre, 100 ascot avenue, remuera, and, auckland New ZealandReported Earnings • Jun 25Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: US$0 (improved from US$0.005 loss in FY 2023). Revenue: US$67.7m (up 21% from FY 2023). Net loss: US$200.0k (loss narrowed 92% from FY 2023). Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Reported Earnings • Jun 04Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: US$0 (improved from US$0.005 loss in FY 2023). Revenue: US$67.7m (up 21% from FY 2023). Net loss: US$200.0k (loss narrowed 92% from FY 2023). Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Reported Earnings • Dec 01First half 2024 earnings released: EPS: US$0 (vs US$0.003 loss in 1H 2023)First half 2024 results: EPS: US$0 (improved from US$0.003 loss in 1H 2023). Revenue: US$13.2m (up 78% from 1H 2023). Net loss: US$100.0k (loss narrowed 94% from 1H 2023). Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Global Forestry industry. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance.공고 • Aug 01ArborGen Holdings Limited Announces Executive ChangesArborGen Holdings Limited announced Adriano E. Amaral de Almeida will assume the role of General Manager of its Brazil operations. Adriano succeeds Gabriela Monnerat, who will continue in a consulting capacity to facilitate a seamless transition. Amaral de Almeida comes to the company with more than 20 years in tree improvement science and breeding. More recently, he was the head of Acacia and Eucalyptus tree improvement at APRIL Indonesia where he was responsible for the tree breeding program, including the biomolecular lab, genomic projects, wood properties lab, Acacia and Eucalyptus seed production, and research and development project management. Amaral de Almeida has a bachelor's degree in forestry engineering from Viçosa Federal University, a master's degree in forest science from Viçosa Federal University, and a master's of innovation management from Campinas University.공고 • Jun 14ArborGen Holdings Limited, Annual General Meeting, Sep 20, 2023ArborGen Holdings Limited, Annual General Meeting, Sep 20, 2023. Location: the Ellerslie Event Centre in Auckland in the Remuera Room Auckland City New ZealandReported Earnings • Jun 01Full year 2023 earnings released: US$0.005 loss per share (vs US$0.003 profit in FY 2022)Full year 2023 results: US$0.005 loss per share (down from US$0.003 profit in FY 2022). Revenue: US$56.1m (up 18% from FY 2022). Net loss: US$2.50m (down 247% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Reported Earnings • Dec 01First half 2023 earnings released: US$0.003 loss per share (vs US$0.001 loss in 1H 2022)First half 2023 results: US$0.003 loss per share (further deteriorated from US$0.001 loss in 1H 2022). Revenue: US$7.40m (up 61% from 1H 2022). Net loss: US$1.60m (loss widened 220% from 1H 2022). Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 1.6% growth forecast for the Global Forestry industry. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Sep 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Jul 03Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: US$0.003 (vs US$0.003 in FY 2021). Revenue: US$47.6m (up 11% from FY 2021). Net income: US$1.70m (up 13% from FY 2021). Profit margin: 3.6% (in line with FY 2021). Revenue missed analyst estimates by 25%. Earnings per share (EPS) also missed analyst estimates by 75%. Over the next year, revenue is forecast to grow 46%, compared to a 18% growth forecast for the industry in New Zealand. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.공고 • Jun 30ArborGen Holdings Limited Announces the Resignation of Ranjan Tandon from BoardArborGen Holdings Limited announced that Ranjan Tandon has notified the Company that he will resign from the ArborGen Board effective 30 June 2022. Mr. Tandon has resigned from the ArborGen Board in order to devote more time to his other commitments, in particular his involvement in philanthropic and other business activities. The ArborGen Board and management would like to recognise the significant contribution that Mr. Tandon has made to ArborGen during his Board tenure and thank Mr. Tandon.공고 • Jun 23ArborGen Holdings Limited, Annual General Meeting, Aug 24, 2022ArborGen Holdings Limited, Annual General Meeting, Aug 24, 2022, at 10:00 NZST - New Zealand Standard. Location: Ellerslie Event Centre in Auckland Remuera Room Auckland City New ZealandReported Earnings • May 31Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: US$0.003 (down from US$0.006 in FY 2021). Revenue: US$47.6m (down 9.7% from FY 2021). Net income: US$1.70m (down 47% from FY 2021). Profit margin: 3.6% (down from 6.1% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 25%. Earnings per share (EPS) also missed analyst estimates by 75%. Over the next year, revenue is forecast to grow 45%, compared to a 11% growth forecast for the industry in New Zealand. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 25First half 2022 earnings: EPS and revenues miss analyst expectationsFirst half 2022 results: US$0.001 loss per share (down from US$0.005 profit in 1H 2021). Revenue: US$4.60m (up 59% from 1H 2021). Net loss: US$500.0k (down 121% from profit in 1H 2021). Revenue missed analyst estimates by 5.0%. Earnings per share (EPS) were also behind analyst expectations. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 21%, compared to a 9.7% growth forecast for the industry in New Zealand.Board Change • Nov 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Oct 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공고 • Jul 01An unknown buyer made an non-binding and an indicative proposal to acquire ArborGen Holdings Limited (NZSE:ARB).An unknown buyer made an non-binding and an indicative proposal to acquire ArborGen Holdings Limited (NZSE:ARB) on June 30, 2021. In light of this, the Board of ArborGen has decided to commence a strategic review.Reported Earnings • May 29Full year 2021 earnings released: EPS US$0.006 (vs US$0.005 loss in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: US$52.7m (down 7.4% from FY 2020). Net income: US$3.20m (up US$5.90m from FY 2020). Profit margin: 6.1% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.분석 기사 • May 14ArborGen Holdings (NZSE:ARB) Hasn't Managed To Accelerate Its ReturnsThere are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...분석 기사 • Feb 13What Do The Returns On Capital At ArborGen Holdings (NZSE:ARB) Tell Us?Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...분석 기사 • Jan 17Does ArborGen Holdings (NZSE:ARB) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...분석 기사 • Dec 22What Type Of Returns Would ArborGen Holdings'(NZSE:ARB) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...Reported Earnings • Nov 28First half 2021 earnings released: EPS US$0.008The company reported a decent first half result with improved earnings and profit margins, although revenues were weaker. First half 2021 results: Revenue: US$11.9m (down 16% from 1H 2020). Net income: US$4.00m (up US$7.00m from 1H 2020). Profit margin: 34% (up from net loss in 1H 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.분석 기사 • Nov 26Are ArborGen Holdings's (NZSE:ARB) Statutory Earnings A Good Guide To Its Underlying Profitability?As a general rule, we think profitable companies are less risky than companies that lose money. However, sometimes...이익 및 매출 성장 예측NZSE:ARB - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수3/31/2029812N/AN/A13/31/2028750N/AN/A13/31/202772-2N/AN/A13/31/202668-704N/A12/31/202566-14-32N/A9/30/202565-20-51N/A6/30/202564-21-52N/A3/31/202563-21-53N/A12/31/202465-12-34N/A9/30/202467-2-16N/A6/30/202468-129N/A3/31/2024680512N/A12/31/202365-1511N/A9/30/202362-1511N/A6/30/202359-239N/A3/31/202356-217N/A9/30/202250105N/A6/30/202249116N/A3/31/202248238N/A9/30/202145-137N/A6/30/202144048N/A3/31/2021432510N/A12/31/2020442N/AN/AN/A9/30/2020463511N/A6/30/202051N/A08N/A3/31/202057-3-55N/A12/31/201955-4N/A4N/A9/30/201954-5N/A3N/A6/30/201951-5N/A3N/A3/31/201949-4N/A4N/A3/31/2018704N/A8N/A9/30/20175-2N/A-2N/A12/31/2016430-18N/A25N/A9/30/2016430-17N/A29N/A6/30/20169011N/A32N/A3/31/20161676N/AN/AN/A12/31/2015244N/AN/A4N/A9/30/20153251N/A2N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: ARB 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(4.2%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: ARB (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: ARB 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: ARB 의 수익(연간 5.4%)이 NZ 시장(연간 4.4%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: ARB 의 수익(연간 5.4%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: ARB의 자본 수익률은 3년 후 2%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/13 20:05종가2026/08/13 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스ArborGen Holdings Limited는 1명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관James LindsayForsyth Barr Group Ltd.
공고 • Nov 29ArborGen Holdings Limited Revises Group Earnings Guidance for the Full Year 2025ArborGen Holdings Limited revised group earnings guidance for the full year 2025. The company's overall goal remains to drive sales of its advanced genetics seedlings in its target markets in the US South and Brazil, both of which offer strong growth and commercial potential. Growth momentum and higher volumes are expected in Brazil in second half of 2025 following the softer first half year. Headwinds in the US South are expected to continue to impact across the industry, resulting in lower demand and offsetting the growth in Brazil. Given this, the company expects full year 2025 sales volumes to be down on last year with a corresponding impact on earnings.
New Risk • Jul 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of New Zealander stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$400k free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$226k net loss in 2 years). Share price has been volatile over the past 3 months (6.2% average weekly change). Market cap is less than US$100m (NZ$33.0m market cap, or US$19.3m).
공고 • Jul 13ArborGen Holdings Limited, Annual General Meeting, Sep 15, 2026ArborGen Holdings Limited, Annual General Meeting, Sep 15, 2026.
New Risk • Jun 02New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$7.5m Forecast net loss in 2 years: US$226k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$400k free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$226k net loss in 2 years). Market cap is less than US$100m (NZ$44.6m market cap, or US$26.5m).
Reported Earnings • May 30Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: US$0.015 loss per share (improved from US$0.041 loss in FY 2025). Revenue: US$68.2m (up 7.9% from FY 2025). Net loss: US$7.50m (loss narrowed 65% from FY 2025). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 8.2% p.a. on average during the next 2 years, compared to a 5.0% growth forecast for the Global Forestry industry. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.
New Risk • Apr 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of New Zealander stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$5.1m free cash flow). Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Market cap is less than US$100m (NZ$45.1m market cap, or US$26.4m).
Reported Earnings • Nov 28First half 2026 earnings released: US$0.001 loss per share (vs US$0.004 loss in 1H 2025)First half 2026 results: US$0.001 loss per share (improved from US$0.004 loss in 1H 2025). Revenue: US$14.2m (up 11% from 1H 2025). Net loss: US$600.0k (loss narrowed 71% from 1H 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.
New Risk • Sep 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of New Zealander stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$5.1m free cash flow). Earnings have declined by 67% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Market cap is less than US$100m (NZ$64.0m market cap, or US$37.8m).
Recent Insider Transactions • Aug 30President & CEO recently bought NZ$82k worth of stockOn the 28th of August, Justin Birch bought around 750k shares on-market at roughly NZ$0.11 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Justin's only on-market trade for the last 12 months.
분석 기사 • Jul 24Cautious Investors Not Rewarding ArborGen Holdings Limited's (NZSE:ARB) Performance CompletelyThere wouldn't be many who think ArborGen Holdings Limited's ( NZSE:ARB ) price-to-sales (or "P/S") ratio of 0.5x is...
공고 • Jul 11ArborGen Holdings Limited, Annual General Meeting, Sep 10, 2025ArborGen Holdings Limited, Annual General Meeting, Sep 10, 2025. Location: auckland New Zealand
Reported Earnings • May 31Full year 2025 earnings released: US$0.041 loss per share (vs US$0 in FY 2024)Full year 2025 results: US$0.041 loss per share (further deteriorated from US$0 in FY 2024). Revenue: US$63.2m (down 6.6% from FY 2024). Net loss: US$21.5m (loss widened US$21.3m from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 107 percentage points per year, which is a significant difference in performance.
New Risk • May 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$5.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$5.1m free cash flow). Earnings have declined by 67% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NZ$76.6m market cap, or US$45.8m).
공고 • Nov 29ArborGen Holdings Limited Revises Group Earnings Guidance for the Full Year 2025ArborGen Holdings Limited revised group earnings guidance for the full year 2025. The company's overall goal remains to drive sales of its advanced genetics seedlings in its target markets in the US South and Brazil, both of which offer strong growth and commercial potential. Growth momentum and higher volumes are expected in Brazil in second half of 2025 following the softer first half year. Headwinds in the US South are expected to continue to impact across the industry, resulting in lower demand and offsetting the growth in Brazil. Given this, the company expects full year 2025 sales volumes to be down on last year with a corresponding impact on earnings.
Reported Earnings • Nov 29First half 2025 earnings released: US$0.004 loss per share (vs US$0 in 1H 2024)First half 2025 results: US$0.004 loss per share (further deteriorated from US$0 in 1H 2024). Revenue: US$12.8m (down 3.0% from 1H 2024). Net loss: US$2.10m (loss widened US$2.00m from 1H 2024). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
공고 • Jul 22ArborGen Holdings Limited, Annual General Meeting, Aug 26, 2024ArborGen Holdings Limited, Annual General Meeting, Aug 26, 2024. Location: hunterville room, ellerslie event centre, 100 ascot avenue, remuera, and, auckland New Zealand
Reported Earnings • Jun 25Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: US$0 (improved from US$0.005 loss in FY 2023). Revenue: US$67.7m (up 21% from FY 2023). Net loss: US$200.0k (loss narrowed 92% from FY 2023). Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Reported Earnings • Jun 04Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: US$0 (improved from US$0.005 loss in FY 2023). Revenue: US$67.7m (up 21% from FY 2023). Net loss: US$200.0k (loss narrowed 92% from FY 2023). Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Reported Earnings • Dec 01First half 2024 earnings released: EPS: US$0 (vs US$0.003 loss in 1H 2023)First half 2024 results: EPS: US$0 (improved from US$0.003 loss in 1H 2023). Revenue: US$13.2m (up 78% from 1H 2023). Net loss: US$100.0k (loss narrowed 94% from 1H 2023). Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Global Forestry industry. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance.
공고 • Aug 01ArborGen Holdings Limited Announces Executive ChangesArborGen Holdings Limited announced Adriano E. Amaral de Almeida will assume the role of General Manager of its Brazil operations. Adriano succeeds Gabriela Monnerat, who will continue in a consulting capacity to facilitate a seamless transition. Amaral de Almeida comes to the company with more than 20 years in tree improvement science and breeding. More recently, he was the head of Acacia and Eucalyptus tree improvement at APRIL Indonesia where he was responsible for the tree breeding program, including the biomolecular lab, genomic projects, wood properties lab, Acacia and Eucalyptus seed production, and research and development project management. Amaral de Almeida has a bachelor's degree in forestry engineering from Viçosa Federal University, a master's degree in forest science from Viçosa Federal University, and a master's of innovation management from Campinas University.
공고 • Jun 14ArborGen Holdings Limited, Annual General Meeting, Sep 20, 2023ArborGen Holdings Limited, Annual General Meeting, Sep 20, 2023. Location: the Ellerslie Event Centre in Auckland in the Remuera Room Auckland City New Zealand
Reported Earnings • Jun 01Full year 2023 earnings released: US$0.005 loss per share (vs US$0.003 profit in FY 2022)Full year 2023 results: US$0.005 loss per share (down from US$0.003 profit in FY 2022). Revenue: US$56.1m (up 18% from FY 2022). Net loss: US$2.50m (down 247% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Reported Earnings • Dec 01First half 2023 earnings released: US$0.003 loss per share (vs US$0.001 loss in 1H 2022)First half 2023 results: US$0.003 loss per share (further deteriorated from US$0.001 loss in 1H 2022). Revenue: US$7.40m (up 61% from 1H 2022). Net loss: US$1.60m (loss widened 220% from 1H 2022). Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 1.6% growth forecast for the Global Forestry industry. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Sep 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Jul 03Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: US$0.003 (vs US$0.003 in FY 2021). Revenue: US$47.6m (up 11% from FY 2021). Net income: US$1.70m (up 13% from FY 2021). Profit margin: 3.6% (in line with FY 2021). Revenue missed analyst estimates by 25%. Earnings per share (EPS) also missed analyst estimates by 75%. Over the next year, revenue is forecast to grow 46%, compared to a 18% growth forecast for the industry in New Zealand. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
공고 • Jun 30ArborGen Holdings Limited Announces the Resignation of Ranjan Tandon from BoardArborGen Holdings Limited announced that Ranjan Tandon has notified the Company that he will resign from the ArborGen Board effective 30 June 2022. Mr. Tandon has resigned from the ArborGen Board in order to devote more time to his other commitments, in particular his involvement in philanthropic and other business activities. The ArborGen Board and management would like to recognise the significant contribution that Mr. Tandon has made to ArborGen during his Board tenure and thank Mr. Tandon.
공고 • Jun 23ArborGen Holdings Limited, Annual General Meeting, Aug 24, 2022ArborGen Holdings Limited, Annual General Meeting, Aug 24, 2022, at 10:00 NZST - New Zealand Standard. Location: Ellerslie Event Centre in Auckland Remuera Room Auckland City New Zealand
Reported Earnings • May 31Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: US$0.003 (down from US$0.006 in FY 2021). Revenue: US$47.6m (down 9.7% from FY 2021). Net income: US$1.70m (down 47% from FY 2021). Profit margin: 3.6% (down from 6.1% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 25%. Earnings per share (EPS) also missed analyst estimates by 75%. Over the next year, revenue is forecast to grow 45%, compared to a 11% growth forecast for the industry in New Zealand. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 25First half 2022 earnings: EPS and revenues miss analyst expectationsFirst half 2022 results: US$0.001 loss per share (down from US$0.005 profit in 1H 2021). Revenue: US$4.60m (up 59% from 1H 2021). Net loss: US$500.0k (down 121% from profit in 1H 2021). Revenue missed analyst estimates by 5.0%. Earnings per share (EPS) were also behind analyst expectations. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 21%, compared to a 9.7% growth forecast for the industry in New Zealand.
Board Change • Nov 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Oct 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공고 • Jul 01An unknown buyer made an non-binding and an indicative proposal to acquire ArborGen Holdings Limited (NZSE:ARB).An unknown buyer made an non-binding and an indicative proposal to acquire ArborGen Holdings Limited (NZSE:ARB) on June 30, 2021. In light of this, the Board of ArborGen has decided to commence a strategic review.
Reported Earnings • May 29Full year 2021 earnings released: EPS US$0.006 (vs US$0.005 loss in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: US$52.7m (down 7.4% from FY 2020). Net income: US$3.20m (up US$5.90m from FY 2020). Profit margin: 6.1% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
분석 기사 • May 14ArborGen Holdings (NZSE:ARB) Hasn't Managed To Accelerate Its ReturnsThere are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
분석 기사 • Feb 13What Do The Returns On Capital At ArborGen Holdings (NZSE:ARB) Tell Us?Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
분석 기사 • Jan 17Does ArborGen Holdings (NZSE:ARB) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
분석 기사 • Dec 22What Type Of Returns Would ArborGen Holdings'(NZSE:ARB) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
Reported Earnings • Nov 28First half 2021 earnings released: EPS US$0.008The company reported a decent first half result with improved earnings and profit margins, although revenues were weaker. First half 2021 results: Revenue: US$11.9m (down 16% from 1H 2020). Net income: US$4.00m (up US$7.00m from 1H 2020). Profit margin: 34% (up from net loss in 1H 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
분석 기사 • Nov 26Are ArborGen Holdings's (NZSE:ARB) Statutory Earnings A Good Guide To Its Underlying Profitability?As a general rule, we think profitable companies are less risky than companies that lose money. However, sometimes...